I. Definitions
A. Chemotherapeutic agent- any agent that inhibits growth, including manmade agents

B. Antibiotic- an antimicrobial agent produced by another living organism
C. Antibiogram- characteristic pattern of resistance
D. Resistance vs Sensitivity
E. Bacteriocidal versus bacteriostatic
A. Toxicity - may require blood levels
B. Action - method of inhibition affecting microbe, best if it selectively targets procaryotic cells
C. Spectrum - narrow (GN or GP or even a particular species e.g. anti-mycobacterial)
D. Target Tissue - selective concentration of a particular antimicrobial e.g. Nitrofurantoin and Gantrisin in bladder, Zithromycin in deep tissues
E. Adverse effects
1. Allergies - some life threatening - medic bracelet
2. Side effects - rashes, nausea, dry mouth
3. Normal flora - may destroy balance
F. Development of resistance - plasmid transfer of resistance factors
1. High Concentration of the drug inhibits development of resistance - stopping prescriptions before finishing encourages resistance.
2. Combination therapy - synergism - can combat development of resistance
3. Limited use of antimicrobials reduces resistance
4. New drug development is expensive, but overcomes resistance
G. Cost - newest and non-generic drugs have heavy R&D embedded cost
H. Administration - Topical, Oral, IM, IV

III. Mechanisms of Antimicrobial Drugs

IV. Types of Agents - This is linked to the antibiotics we will use in class
| Antibiotic | Names of common drugs | Target Organisms & Infections | Special Concerns |
| Drugs that target cell wall synthesis - beta lactams and betal lactamase** | |||
|
Penicillins - interrupt linkages of peptidoglycan |
Penicillin, Ampicillin Carbenicillin, Amoxicillin, Methicillin | Gram Positive organisms | Allergies Beta lactamase |
|
Cephalosporins |
Cephalexin, Cefaclor, Cefexim | GN & GP | more resistant to Beta lactamase |
|
Carbapenems |
Imipenem | GN & GP | most resistant to Beta lactamase |
|
Vancomycin |
Vancomycin | GP | Last line against MRSA |
|
Bacitracin |
Bacitracin | GP & GN | only used topically |
|
Drugs that target protein synthesis |
|||
|
Aminoglycosides binds to ribosomes blocks translation |
Streptomycin, Gentamicin, Tobramycin, Neomycin (topical only) | Broad spectrum but often used synergistically with cephalosporins | severe hearing and kidney damage must draw blood levels
|
|
Tetracyclines blocks tRNA stopping protein synthesis |
Tetracycline, Minocycline, Doxycycline | Only works on procaryotic cells | Sun sensitivity, bone and tooth damage in children |
|
Macrolides prevent protein synthesis by binding to ribosomes |
Erythromycin, Zithromycin | Mycoplasma, GP, some GN |
Used for Penicillin allergic patients |
|
Chloramphenicol prevents peptide synthesis bonding by ribosomes |
Chloramphenicol | Broad spectrum | May inhibit bone marrow production (aplastic anemia) |
|
Drugs that target nucleic acid synthesis |
|||
|
Fluoroquinolones - inhibit DNA gyrase interupting DNA replication |
Ciprofloxacin, Ofloxacin, Lomefloxacin | Very Broad spectrum | increasing resistance noted |
|
Rifampin blocks RNA activity in ribosomes |
none | GN and Mycobacteria | Quick resistance development |
| Drugs that inhibit Metabolic Processes | |||
| Sulfonamides - imitate PABA and disrupt folic acid metabolism | Sulfa drugs Gantrisin |
GN, some GP | allergic reactions, sun sensitivity |
|
Trimethoprim |
SXT, Bactrim | Broad | Synergistic use of sulfa with trimethoprim - sulfamethaoxazole/trimethoprim |
|
Drugs that target cell membrane integrity |
|||
|
Polymyxin B |
Polymyxin B | GN | Topical only |
| Amphotericin B | Amphotericin B | Fungi | Very harsh side effects |
| Drugs that target AFB - See Sanford Table 11B | |||
|
Ethambutol - interrupt mycolic acid formation in call wall |
Ethambutol |
Mycobacteria | used synergistically in multidrug therapy |
| INH Isoniazid - interrupt mycolic acid formation in call wall | INH Isoniazid | Mycobacteria | used synergistically in multidrug therapy |
| Clofazimine - prevents replication and transcription | Lamprene | Mycobacterium leprae | |
| Drugs that inhibit viral infections - Sanford Table 14 A | |||
| Arildone - attachment antagonists | Picornavirus - polio | ||
| Amantadine - inhibits viral uncoating(Symmetrel, Rimantadine, Flumadine) | Influenza | CNS side-effects | |
| Ribavirin (Virazole) | RSV | Anemia, rash - do not use in pregnancy | |
| Anti-retroviral drugs | |||
| Acyclovir family (Famicyclovir, Penciclovir) - Inhibit nucleic acids (Zovirax) | HIV | phlebitis and vesicular lesions | |
| Protease inhibitors - blocks active site | HIV | ||
See Table 6 in Sanford Guide
V. Antibiotic Effectiveness testing
A. Kirby Bauer


B. MIC - provides exact concentration


VI. Antibiotic Resistance
A. MRSA, Pseudomonas, VRE
B. Abuse
1. Artificial selection
2. Developing countries
3. Animal feed -
VII. Antiviral Drug Mechanisms

A. Viral Uncoating
B. Nucleic Acid Analogs
C. Protease Inhibitors
D. Refer to Text Book Table 10.3


VIII. Antifungal Drug Mechanisms

A. Plasma Membrane disruption

IX. Antiparasitic Drug Mechanisms
A. Plasma membrane disruption
B. Interruption of cell division
C. Inhibition of nucleic acid synthesis
D. Refer to Textbook table 10. 4
IX. Antiprotozoal Drugs & Mechanisms
A. Heavy Metals – interfering with protein shape and reactivity
B. Quinine – inhibits DNA synthesis
C. Sulfonamides & Trimethoprim– competitive inhibitor for specific enzymes
D. Nitroimidazoles – e.g. Metronidazole
E. See Textbook table 10.6


X. Anti-Helminthic Drugs
A. Mebendazole – inhibits enzymes in Mitosis
B. Praziquantel & Piperazine – paralyses worms
C. Niclosamide – inhibits ATP
D. See textbook table 10.5

Chapter 10 Controlling Microbial Growth in the Human Body Antimicrobial Drugs
1. Describe the
mechanism of competitive inhibition using the example of sulfanilamides to
interrupt the growth of bacteria.
2. Describe
the action of antimicrobials in the penicillin
family and drawbacks
to their use.
3. Compare the cephalosporin and penicillin antibiotics with respect to source, structure, spectrum of activity, and side effects.
4. When given a clinical infection, use the Sanford guide to determine the empirical treatment and potential side effects.
5. State several examples and describe the chemical structure, uses, and side effects of tetracycline antibiotics.
6. Explain the unique dosage and use of antimicrobials for Mycobacterial infections.
7. Draw a bacterial cell and indicate the physical area or pathways affecting by each of the major groups of antibiotic families.
Bakersfield College | Kern Community College District |
Janet Fulks
1801 Panorama Dr. - Bakersfield, CA 93305 - (661)395-4381
Date last updated
03/04/2008
©Janet Fulks